“…The use of a pseudopregnancy model here provided several advantages over use of single or multiple injection or chronic implant, as reported earlier: (1) it is a more physiological paradigm than the other procedures, because progesterone is produced by an endogenous, ovarian source; (2) the time course of progesterone exposure, with progesterone elevated from day 4 to 12, is similar to progesterone exposure during the luteal phase of the menstrual cycle (Dennerstein et al, 1985;Rapkin et al, 1997), thus making this a usef ul model for PMS and postpartum conditions; (3) not only are progesterone and 3␣,5␣-THP released, but a number of other steroids are also naturally released by the ovary and corpus luteum, also making this a better in vivo model (Robinson et al, 1981;K im and Greenwald, 1986); (4) release of progesterone under physiological states, such as estrus, pregnancy, and pseudopregnancy is somewhat episodic (Robinson et al, 1981;K im and Greenwald, 1986), a phenomenon that could not easily be replicated by artificial means of administration. The fact that hormone release is episodic in this model may explain why a single withdrawal cycle was effective in the present study in triggering withdrawal properties, whereas in earlier studies, multiple withdrawal cycles were required (Costa et al, 1995;Smith et al, 1998).…”